Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG2BG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,287
Award facts
- Contract value 100% obligated
- $37,286.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dupixent 300 mg/2 ml syringes valued at $37,286.90 with a completion date of December 10, 2025. This competitive, non-set-aside contract utilizes firm fixed price pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse military medical supply requirements across multiple therapeutic domains through open competition. The current delivery order for Dupixent—a biologic medication used to treat conditions such as eczema, asthma, and other allergic inflammatory conditions—represents a typical transaction within the company's federal medical supply operations.
Quick answers
Who was awarded contract SPE2DR26FG2BG?
SPE2DR26FG2BG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FG2BG worth?
The government has obligated $37,287 on SPE2DR26FG2BG.
Is contract SPE2DR26FG2BG an order under another contract?
Yes. SPE2DR26FG2BG is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2BG competed?
The extent of competition for SPE2DR26FG2BG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award